Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Condition:   HER2-positive Breast Cancer Interventions:   Drug: Docetaxel;   Drug: Carboplatin;   Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Trastuzumab emtansine Sponsor:   University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials